CAS 21122-68-9

Mefenamic Acid EP Impurity B

CAS : 21122-68-9

Formule : C₂₃H₂₄N₂O

Couleur et forme : White To Off-White Solid

Masse moléculaire : 344.46

Ref: 4Z-M-016

Mefenamic Acid EP Impurity B

Produit contrôlé

CAS : 21122-68-9

Formule : C₂₃H₂₄N₂O

Couleur et forme : Neat

Masse moléculaire : 344.45

Ref: 86-MM0327.02

Mefenamic Acid EP Impurity B

CAS : 21122-68-9

Formule : C₂₃H₂₄N₂O

Masse moléculaire : 344.45

Ref: ST-EA-CP-M4002

N-(2,3-Dimethylphenyl) Mefenamic Acid Carboxamide

Produit contrôlé

CAS : 21122-68-9

Impurity Mefeneic Acid EP Impurity B
Applications N-(2,3-Dimethylphenyl) Mefenamic Acid Carboxamide is a derivative of Mefenamic Acid (M205050); an anti-inflammatory agent and analgesic.
References Winder, C.V., J. Pharmacol. Exp. Ther., 138, 405 (1962)

Formule : C₂₃H₂₄N₂O

Couleur et forme : Neat

Masse moléculaire : 344.45

Ref: TR-D477945

N-(2,3-Dimethylphenyl) mefenamic acid carboxamide

CAS : 21122-68-9

2,3-Dimethylphenyl mefenamic acid is a synthetic drug product. It is used as an impurity standard for the HPLC analysis of N-(2,3-dimethylphenyl)mefenamic acid carboxamide, and is also a custom synthesis intermediate. 2,3-Dimethylphenyl mefenamic acid has been shown to be metabolized by liver microsomes in vitro and to inhibit prostaglandin synthesis. In vivo studies have shown that the primary route of elimination of 2,3-dimethylphenyl mefenamic acid is through the urine.
2,3-Dimethylphenyl mefenamic acid has been shown to be effective in inhibiting prostaglandin synthesis in vitro and in vivo studies. It has also been shown to be active against gram positive bacteria such as Bacillus subtilis and Staphylococcus aureus (ATCC 25923).

Formule : C₂₃H₂₄N₂O

Degré de pureté : Min. 95%

Masse moléculaire : 344.4 g/mol

Ref: 3D-WAA12268